TherapeuticsMD to Host First Quarter 2015 Financial Results Conference Call and Webcast May 5

TherapeuticsMD, Inc. (NYSE MKT: TXMD), an innovative women’s healthcare company, today announced that it will hold a conference call and live audio webcast to discuss first quarter 2015 financial and business results on Tuesday, May 5. The conference call and webcast will take place at 4:30 p.m. EDT. TherapeuticsMD CEO Robert G. Finizio and Chief Financial Officer Dan Cartwright will host the call.

Details for the call and webcast include:

Shortly after completion of the call and webcast, audio and webcast replays will be available for at least 30 days on the company's website, www.therapeuticsmd.com, in the “Investor” section. In addition, a digital recording of the conference will be available for replay beginning two hours after the call's completion and for at least 30 days with the dial-in 855-859-2056 and Conference ID: 28458424.

About TherapeuticsMD, Inc.

TherapeuticsMD, Inc. is an innovative healthcare company focused on developing and commercializing products exclusively for women. With its patented SYMBODA™ technology platform, TherapeuticsMD is developing advanced hormone therapy pharmaceutical products to enable delivery of bio-identical hormones through a variety of dosage forms and administration routes. The company’s clinical development pipeline includes two phase 3 products. The company also manufactures and distributes branded and generic prescription prenatal vitamins as well as over-the-counter vitamins under the vitaMedMD® and BocaGreenMD® brands. More information is available at the following websites: www.therapeuticsmd.com, www.vitamedmd.com, www.vitamedmdrx.com and www.bocagreenmd.com.